TATerkaa Atim

Terkaa Atim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Terkaa Atim has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Low Intensity Shockwave Therapy for Erectile Dysfunction: Keeping Hope Alive

    by Obiatuegwu Kenenna, Magnus Felix, Atim Terkaa, Aniede Ernest

    Introduction: Erectile dysfunction (ED) is defined as persistent inability to achieve and sustain an erection sufficient for satisfactory sexual performance. The prevalence of ED increases with aging from 9% in men younger than 40 years to 71% in older men. ED impacts negatively on sexual performance and quality of life (QoL). Low-intensity shockwave therapy (LiSWT) for ED is a regenerative therapy and contrary to other current therapeutic options which are mainly palliative, it restores the erectile mechanism enabling natural or spontaneous erections. LiSWT has found significant usefulness in the treatment of ED with potential to induce angiogenesis and dislodge plaques which will invariably improve blood flood to the penis leading to a lifelong solution to ED with marked improvement in sexual performance. Methodology: This is a prospective randomized study. All patients presenting to andrology clinic with erectile dysfunction were enrolled in the study. Informed consent was obtained. All patients were evaluated to identify the likely etiology and a proforma and standard abridged version of International Index of Erectile Function (IIEF-5) were administered. An Emshock and Smart Tecar 2 in 1 device was used to deliver low intensity shockwave to the penis at 5 different sites and treatment sustained twice a week for 3 weeks to complete a cycle before reassessment with IIEF-5 questionnaire. Data obtained were analyzed using Statistical Package for Social Sciences version 22.0. Results were represented in charts. P value of less than 0.005 was considered statistically significant. Results: Fifty four patients were enrolled in the study. The enrolled patients fell within the age ranges of 34 to 63 years. The identifiable etiology of ED were unknown in 22.22%, diabetes mellitus in 46.30%, hypertension in 18.52% and a combination of hypertension and diabetes in 13%. All patient enrolled for the study had varying degree of abnormal IIEF-5 score. Twelve patients (22.22%) had mild ED, eleven patients (20.37%) had mild to moderate ED, one patient (1.85%) had moderate ED and thirty patients (55.56%) had severe ED. All patients had varying significant improvement in erectile function and IIEF-5 score after the first treatment cycle. Eighteen patients (33.33%) achieved normal erection evidenced by progression to normal IIEF-5 while 36 patients (66.66%) achieved significant progress evidenced by improvement in IIEF-5 score. 4 patients had spontaneous erection that lasted more than 20 minutes during each treatment encounter. No patient had side effect and the patient satisfaction was one hundred percent. Conclusion: LiSWT remains revolutionary as a regenerative therapy for restoration to physiological erectile function possibly possessing unprecedented qualities that can rehabilitate erectile tissue. While results of several studies are variable, one thing that is found across many literatures is the low risk and lack of side effects of LiSWT. Its main benefit is the ability to support and potentially restore erectile function in men with ED without additional pharmacotherapy.

  • Open Access

    Metabolic Reprogramming as a Therapeutic Target in Cancer: A Qualitative Systematic Review (QualSR) of Natural Compounds Modulating Glucose and Glutamine Pathways

    by Michael Enwere, Edward Irobi, Victoria Chime, Ada Ezeogu, Adamu Onu, Mohamed Toufic El Hussein, Gbadebo Ogungbade, Emmanuel Davies, Omowunmi Omoniwa, Charles Omale, et al.

    Background: Despite advances in gene-targeted and immunotherapies, many aggressive cancers—including glioblastoma and triple-negative breast cancer—remain refractory to treatment. Mounting evidence implicates metabolic reprogramming, especially dysregulation of glucose and glutamine metabolism, as a core hallmark of tumor progression. Natural compounds with metabolic-modulatory effects have emerged as promising adjuncts in oncology. Research Question and Objectives: This review investigates the following question: How can metabolic-targeted therapies—particularly those modulating the Warburg effect and glutamine metabolism—improve cancer treatment outcomes, and what role do natural compounds play in this strategy? The objectives were to (1) evaluate the therapeutic potential of metabolic interventions targeting glucose and glutamine metabolism, (2) assess natural compounds with metabolic regulatory activity, (3) examine integration of metabolic-targeted therapies with conventional treatments, and (4) identify metabolic vulnerabilities in resistant malignancies. Methods: A qualitative systematic review (QualSR) was conducted following PRISMA guidelines. A total of 87 peer-reviewed studies published between 2000 and 2024 were included. Inclusion criteria required clearly defined mechanistic or clinical endpoints and, for clinical trials, sample sizes ≥ 30. Data extraction focused on tumor response, survival, metabolic modulation, and safety profiles. Results: Curcumin significantly reduced serum TNF-α and IL-6 (both p = 0.001) and improved antioxidant capacity (p = 0.001). EGCG downregulated ERα (p = 0.002) and upregulated tumor suppressors p53 and p21 (p = 0.001, p = 0.02). High-dose intravenous vitamin C combined with chemoradiotherapy yielded a 44.4% pathologic complete response rate in rectal cancer. Berberine suppressed Akt/mTOR signaling and glutamine transporter SLC1A5 across tumor types (q < 10−10). However, poor bioavailability (e.g., EGCG t½ = 3.4 ± 0.3 h) and systemic toxicity limit their standalone clinical application. Conclusions: Metabolic-targeted therapies—particularly natural compounds acting on glucose and glutamine pathways—offer a viable adjunct to standard cancer therapies. Clinical translation will require biomarker-driven patient stratification, improved delivery systems, and combination trials to optimize the therapeutic impact in treatment-resistant cancers.


  • Open Access

    Keystone Species Restoration: Therapeutic Effects of Bifidobacterium infantis and Lactobacillus reuteri on Metabolic Regulation and Gut-Brain Axis Signaling—A Qualitative Systematic Review (QualSR)

    by Michael Enwere, Edward Irobi, Adamu Onu, Emmanuel Davies, Gbadebo Ogungbade, Charles Omale, Mercy Neufeld, Victoria Chime, Ada Ezeogu, Dung-Gwom Pam Stephen, et al.

    Background: The human gut microbiome—a diverse ecosystem of trillions of microorganisms—plays a critical role in metabolic, immune, and neurological regulation. However, modern lifestyle factors such as antibiotic overuse, cesarean delivery, reduced breastfeeding, processed and high-sodium diets, alcohol intake, smoking, and exposure to environmental toxins (e.g., glyphosate) have significantly reduced microbial diversity. Loss of keystone species like Bifidobacterium infantis and Lactobacillus reuteri contributes to gut dysbiosis, which has been implicated in chronic metabolic, autoimmune, cardiovascular, and neurodegenerative conditions. Materials & Methods: This Qualitative Systematic Review (QualSR) synthesized data from over 547 studies involving human participants and standardized microbiome analysis techniques, including 16S rRNA sequencing and metagenomics. Studies were reviewed for microbial composition, immune and metabolic biomarkers, and clinical outcomes related to microbiome restoration strategies. Results: Findings reveal a 40–60% reduction in microbial diversity among Western populations compared to traditional societies, particularly affecting SCFA-producing bacteria. Supplementation with B. infantis was associated with a significant reduction in systemic inflammation—including a 50% decrease in C-reactive protein (CRP) and reduced TNF-α levels—alongside increases in regulatory T cells and anti-inflammatory cytokines (IL-10, TGF-β1). L. reuteri demonstrated additional immunomodulatory effects and neurobehavioral benefits in preclinical models. Restoration interventions led to a 30–45% increase in tight junction protein expression and a 25–50% reduction in overall inflammation, suggesting improved gut barrier function and systemic immune balance. Conclusion: Restoring gut microbiota diversity through keystone species like B. infantis and L. reuteri holds therapeutic potential for a wide range of chronic inflammatory, metabolic, and neuroimmune disorders. Strengthening gut barrier integrity and reducing systemic inflammation by up to 50% underscores the microbiome’s relevance in immunometabolic health. Future research should emphasize personalized microbiome profiling, long-term outcomes, and transgenerational effects of early-life microbial disruption.


  • Operative Technique and Short-term Outcome of Re-do Failed Hypospadias Repair: A Case Report

    by Obiatuegwu Kenenna, Magnus E, Atim Terkaa, Otabor Christopher

    Introduction: A failed hypopadias repair is a difficult case to treat considering the poor quality of surrounding tissues arising from disruption of normal vasculature associated with the underlying disorder as well as scaring from previous repairs. In this case report we describe our experience with the management of late presentation of failed hypospadias repair in a 12 year old boy. Case report: Our patient is a twelve year old ‘small for age’ who presented to our center with failed mid-penile hypospadias repair. He first presented at the age of eight to another hospital where he was evaluated and a diagnosis of mid-penile hypospadias with significant chordee was made. He had the first repair at the age of eight but the repair failed two weeks after surgery. Two years later he had a second repair in same facility which also failed after approximately two weeks. They consequently presented to our center two years later at the age of twelve. Following appropriate evaluation and counseling, he had the 3 rd repair during which we ensured a preoperative sterile urine culture, created a urinary diversion via suprapubic cystostomy, the use of a monofilament (monocryl) suture, complete release of chordee after excision of scar tissues, a second intervening layer over the repair, the use of an improvised stent instead of a urethral catheter and appropriate anchorage of the stent to the suprapubic skin using a nylon suture. Patient did well post-operatively and was discharged home 14 days after the repair. Subsequent outpatient visits were uneventful and he was discharged after three months to see us only when necessary. Conclusion: This case report suggests recurrent ventral chordee and wound dehiscence as the possible risk factors for re-operation, while detailing complete release of chordee and appropriate tubularization urethroplasty technique as tips for success.

  • Open Access

    Premature Ejaculation: Prevalence and Relationship with Body Mass Index

    by Obiatuegwu Kenenna, Atim Terkaa, Magnus Felix, Otabor Christopher, Abu Sadiq

    Introduction: Premature ejaculation is one of the major disorders of sexual functions in males. The prevalence rate of 25-40% has been reported across all age groups globally. Ejaculation latency is affected by psychosomatic factors which may include obesity but the relationship between PE and obesity have not been well documented in sub-Saharan Africa. This study evaluates the prevalence of PE and correlation between PE and body mass index. Methods: This is a prospective cross-sectional study carried out in Federal Capital Territory (FCT) Abuja, Nigeria over a period of 2 years from January 2019 to December 2020. By simple random sampling, participants were recruited for the study. Two questionnaires (a proforma and PEDT) were administered to all the participants who gave consent to be enrolled and met the inclusion criteria. Two basic anthropometric measurements (weight and height) were objectively obtained. Data obtained were analyzed using Statistical Package for Social Sciences version 20.0. P value of less than 0.05 was considered statistically significant. Results: A total of 426 persons participated in the study. Majority of the participants (51.88%) fell within the age range of 20-30 years, while seventy-five participants (17.61%) were between the age ranges of 31-40 years. Those that fell within the age range of 41-50, 51-60, and 61-70 years were 16.43%, 8.22% and 5.87% respectively. Seventy-two participants (16.9%) had PE while three hundred and six participants (71.83%) had no PE. Probable/borderline PE was noted in 48 (11.27%) participants. Mean age of participants with PE was 27.88 years while the mean age of participants with borderline PE was 25.67 years. Mean age of participants with no PE was 41.85 years. Sixty-seven participants (15.73%) were obese, 131 (30.75%) were overweight while 228 (53.52%) had normal BMI. Amongst the participants who had PE, 48 (66.67%) had normal BMI, 16 (22.22%) were overweight while 8 (11.11%) were obese. Majority of participants (66.67%) with probable/borderline PE had normal BMI, 16.67% were overweight while 16.67% were obese. P value of less than 0.05 was significant. Conclusion: This study shows that premature ejaculation is common amongst all age group and has a variable relationship with body habitus, possibly dependent on the sub-type of premature ejaculation. There was an inverse correlation between PE and BMI in younger populations which suggests a lifelong sub-type. PE was also commoner in leaner younger participants and the number of participants with PE decreased as BMI increased.

  • Open Access

    OuadMix Penile Injection: An Initial Urologists Experience

    by Obiatuegwu Kenenna, Atim Terkaa, Magnus Felix, Otabor Christopher, Amu Okwudili, Abu Sadiq

    Introduction : QuadMix is considered to be one of the most powerful class of anti-erectile dysfunction agents and superior to all forms of intracavernosal injections especially in men with permanent/severe erectile dysfunction (ED) that has defiled oral therapy. QuadMix consists of papaverine HCl, phentolamine mesylate, prostaglandin E1 and atropine sulfate designed to act synergistically with satisfactory endpoint. We report our preliminary experience with QuadMIX in the management of permanent/severe ED. Methodology : This is a prospective study which was carried out between July 2020 to June 2022. Two questionnaires (a proforma and IIEF-5) were administered to all patients presenting with ED to objectively assess the etiology, risk factors and severity of ED without bias. Only patients who met the inclusion criteria were recruited for the study and informed consent was obtained. Individual test dose was calculated and the patients were subsequently trained on self-injection using an autoinjector. Two capsules of phenylephrine were also given to the patients to keep with them with appropriate instructions. Data obtained were analyzed using Statistical Package for Social Sciences version 20.0. P value of less than 0.005 was considered statistically significant. Results : Sixty patients were enrolled for the study. All patient had either permanent ED or severe ED. Thirty percent had radical prostatectomy surgery. Ten percent had trauma with pelvic bone involvement while 31.66%, 3.34% and 25% had comorbid conditions (diabetes mellitus and hypertension), prolonged priapism and no obvious organic etiology respectively. Forty percent of the patients failed to achieve satisfactory erection on oral medication while 60% had no erection despite taking phosphodiesterase type 5 inhibitors (PDE5i). All patients had tumescence for satisfactory sexual intercourse within 10 mins following administration of QuadMix. Fifty eight patients (96.67%) had spontaneous detumescence after ejaculation. Only 2 patients (3.34%) had priapism. One was reversed with ejaculation, use of ice pack around the perineum and caps phenylephrine while the second patient had intracavernosal aspiration to achieve detumescence. Conclusion : QuadMix is an effective and safe agent in the treatment of permanent and severe ED in patients with comorbid condition. It also improves quality of life (QoL) and sexual performance in patient who has had permanent ED following radical prostatectomy.


  • Open Access

    The Predictive Value of Prostate Specific Antigen Density, Percentage Free Prostate Specific Antigen and the Combination for Prostate Cancer Detection in Grey Zone

    by Magnus E, Obiatuegwu Kenenna, Atim Terkaa, Otabor Christopher, Dakum Nuhu, Ramyil Venyir

    Introduction: Prostate cancer is a common malignancy affecting men beyond the middle age. In advanced countries, the life time risk of developing microscopic prostate cancer in men is 30%. However, it is slow-growing and the risk of developing clinical disease is 16%, while the lifetime risk is 3%. It is not common in those below 50 years, but after this age there is a steady increase in its incidence. The objective of this study was to determine the predictive value of prostate specific antigen density (PSAD), percentage free Prostate specific antigen and the combination (PSAD+%FPSA) for cancer detection in the grey zone at a tertiary health center in north central Nigeria. Methodology: A prospective study which was carried out over one year and three months. Each subject had a clinical evaluation involving relevant history, physical examination with digital rectal examination of the prostate gland, followed by blood sampling for both total and free PSA. These samples for PSA were sent to the chemical pathology laboratory. The percentage free PSA was calculated by finding the ratio between free PSA and total PSA and multiplying the result by 100. Also, a transabdominal ultrasound scan was done to determine the prostate volume. The PSA density was calculated by dividing the PSA by the total prostate volume. All patients had digitally guided transrectal prostate biopsy. The analysis were in 3 subsets; PSAD, %FPSA and the combination (PSAD+%FPSA). Results were analysed using SPSS version 20. P value Results: Forty two men with mean age of 67.93 ± 7.11years who had PSA in the grey zone were recruited. Only 5(12%) had diagnosis of prostate adenocarcinoma. Mean age of those with adenocarcinoma was 69.40 ± 1.67years. There was no statistically significant correlation between prostate adenocarcinoma and the variables; PSAD, %FPSA and the combination (PSAD+%FPSA), with P values of 0.517, 0.453 and 0.451 respectively. However when the ROC curve was drawn, the AUC was highest for PSAD at 0.524 with a cut-off value of 0.108ng/ml 2 . While the AUC and cut-off was 0.373, 29.40 and 0.373, 30.50 for %FPSA and the combination (PSAD+%FPSA) respectively. Additionally, using a two-by-two table, the positive predictive value for adenocarcinoma was 21.1% for PSAD, compared to 11.9% for %FPSA and 7.1% for the combination. Conclusion: The study showed that PSAD was the most predictive of the 3 parameters. A PSAD cut-off value of 0.108 (sensitivity of 80% and specificity of 20%) is suggestive of prostate adenocarcinoma in patients with PSA in the grey zone.

  • Open Access

    Retroperitoneal paraganglioma causing proximal ureteric obstruction in a child; diagnostic conundrum and immunohistochemistry characteristics: case report

    by Terkaa AtimJoshua, Joshua Oluwafemi Aiyekomogbon

    Paragangliomas are extremely rare neuroendocrine tumors with an incidence of 0.3 cases per million in children. They arise from several sites in the body including the orbit, ear, nose, larynx, carotid area, mediastinum, duodenum, and the genitourinary tract. Germline mutations have been identified in paragangliomas involving the proto-oncogene RET, tumor suppressor genes VHL, and NF1 The commonest clinical presentation is hypertension but incidentally detected forms have been reported during imaging and on a few occasions the diagnosis was missed. The authors report on a case of a 12-year-old male with a history of fever, left flank pain, vomiting, and headaches, finally diagnosed by pathological examination of a resected retroperitoneal mass invading the proximal left ureter. Immunohistochemistry was positive for neuron-specific enolase, NSE (chief cells), and S-100 protein (sustentacular cells) all consistent with paragangliomas. The challenges faced by the team in the preoperative evaluation and surgical treatment are reported.


  • Open Access

    Evaluation of erectile dysfunction in the ageing men using colour Doppler sonography

    by J. O. Aiyekomogbon, D. U. Itanyi, T. Atim, J. B. Igashi


  • Open Access

    Prevalence of Erectile Dysfunction and Awareness of Its Treatment in Abuja, Nigeria

    by S. Abu, T. Atim, N. R. Ripiye

    Introduction: Erectile dysfunction (ED) is the most common male sexual dysfunction all over the World. It is underestimated in developing countries including Nigeria because it is assumed not to be a life threatening condition which is associated with stigmatization and poor health seeking behavior. The Prevalence rate of ED among specific age groups has not been reported in most available local studies. This study was aimed at determining the prevalence rates of ED and the severity of ED among different age groups and patients’ awareness of its treatment. Methods: The study was a descriptive cross-sectional hospital based survey among men aged 18 years and above seen in the outpatient clinics of University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria. Self reported erectile dysfunction was obtained using proforma. The prevalence and severity of ED was obtained using International Index of Erectile Function-5 Questionnaire (IIEF-5). Results: A total of 378 subjects were recruited for this study with age range of 18-76 years. The prevalence of ED in this study using IIEF-5 was 66.4%. The prevalence of ED was noted to increase with increasing age as ED was more prevalent (59%) among men aged 60-79 year. ED was least common among the young subjects (15.7%) and the most severe ED found among the elderly There was a positive correlation between age and ED (rho =0.306). There was statistically significance association between ED and co-morbidities with hypertension accounting for 22.5% and diabetes 16.7%. The percentage of subjects aware of treatment for ED was 39.4% and 20.4% of the subjects had sought help from doctors. Only about a quarter (26.5%) of the subjects had their sexual challenges discussed with the doctor. Conclusion: ED is a common medical and social problem in our environment though still shrouded in secrecy. ED is more prevalent and severe among age 60-79 years. Awareness of treatment seeking behavior and the ability of the attending physicians to discuss with men about their sexual health remains quite poor in our environment.